Eris Lifesciences Ltd.

1,328.20.17%

2026-08-21

eris.co.inBSE: 540596NSE: ERIS
Market Cap₹ 18,683 Cr.
Current Price₹ 1,326
High / Low₹ 1,819 / 1,200
Stock P/E0.0
Book Value₹ 234
Price to Book7.70
Dividend Yield0.53 %
ROCE7.0 %
ROE3.1 %
Face Value₹ 1

Add ratio to table

ABOUT

KEY POINTS

PROS

  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.76x)

CONS

  • Recent results are weak - TTM profit is down 42.2% versus prior year
  • A large part of profit comes from other income (29.6% of PBT)
  • Interest coverage is weak at 1.5x - earnings barely cover interest
  • Company has delivered a poor profit growth of -23.3% over past five years
  • Operating margins have contracted to 28.0% from 40.9%
  • Stock is trading at 7.7x its book value

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.SUNPHARMA1898.0037.65455393.780.842901.2326.5315299.8810.9819.1128.81
2.DIVISLAB8525.0077.37226311.960.35902.0065.503080.0027.8021.5140.75
3.TORNTPHARM5013.0087.43190678.410.76566.003.284921.0057.3219.2733.81
4.CIPLA1416.0033.94114392.010.92785.55-39.187119.284.1316.0016.73
5.ZYDUSLIFE1105.0024.42110224.170.09990.20-34.908017.0023.9721.3924.54
6.LUPIN2220.0018.36101506.150.811416.9816.018276.8934.2828.8629.59
7.MANKIND2391.0048.3498747.340.04574.0929.124030.5912.8913.2426.30
8.DRREDDY1171.0030.3397740.540.68435.60-69.108099.80-5.2113.7510.63
9.LAURUSLABS1807.0089.3097634.420.113620.702139.4220263.101191.0018.2031.50
10.AUROPHARMA1615.1525.0392932.160.251032.0325.229150.3517.4412.7620.54
11.BIOCON414.30136.3267518.230.12136.8053.364336.0010.893.2619.54
12.ERIS1348.1529.0218683.110.53143.3214.56873.2513.1813.5933.88
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023
404
256
Operating Profit
OPM %
Other Income
4
Interest
7
Depreciation
20
133
Tax %
16.43%
Net Profit
111
8
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Sep 2023
402
265
Operating Profit
OPM %
Other Income
7
Interest
7
Depreciation
25
120
Tax %
1.76%
Net Profit
118
9
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Dec 2023
316
250
Operating Profit
OPM %
Other Income
3
Interest
15
Depreciation
28
35
Tax %
8.63%
Net Profit
32
2
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Mar 2024
332
262
Operating Profit
OPM %
Other Income
20
Interest
29
Depreciation
29
42
Tax %
5.37%
Net Profit
40
3
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Jun 2024
449
333
Operating Profit
OPM %
Other Income
5
Interest
56
Depreciation
46
27
Tax %
36.47%
Net Profit
17
1
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Sep 2024
429
294
Operating Profit
OPM %
Other Income
6
Interest
56
Depreciation
46
46
Tax %
38.94%
Net Profit
28
2
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Dec 2024
390
300
Operating Profit
OPM %
Other Income
8
Interest
55
Depreciation
47
6
Tax %
70.48%
Net Profit
2
0
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Mar 2025
396
284
Operating Profit
OPM %
Other Income
17
Interest
53
Depreciation
43
41
Tax %
26.01%
Net Profit
30
2
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Jun 2025
568
362
Operating Profit
OPM %
Other Income
23
Interest
45
Depreciation
38
156
Tax %
36.01%
Net Profit
100
7
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Sep 2025
638
354
Operating Profit
OPM %
Other Income
24
Interest
46
Depreciation
39
235
Tax %
36.26%
Net Profit
150
11
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Dec 2025
307
238
Operating Profit
OPM %
Other Income
25
Interest
45
Depreciation
39
4
Tax %
20.57%
Net Profit
3
0
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Mar 2026
268
256
Operating Profit
OPM %
Other Income
27
Interest
43
Depreciation
39
-33
Tax %
73.76%
Net Profit
-9
-1
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Jun 2026
444
406
Operating Profit
OPM %
Other Income
26
Interest
42
Depreciation
40
64
Tax %
24.70%
Net Profit
48
0
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016
605
435
Operating Profit
174
OPM %
29
Other Income
3
Interest
0
Depreciation
20
154
Tax %
10
Net Profit
138
EPS
10,034
Dividend Payout %
60
Minority Interest
0
Share of Associates
0
Adjusted EPS
10
Minority Interest
0
Share of Associates
0
Adjusted EPS
10
Mar 2017
713
442
Operating Profit
296
OPM %
42
Other Income
25
Interest
1
Depreciation
21
274
Tax %
9
Net Profit
248
EPS
18
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
18
Minority Interest
0
Share of Associates
0
Adjusted EPS
18
Mar 2018
761
445
Operating Profit
344
OPM %
45
Other Income
28
Interest
10
Depreciation
22
312
Tax %
6
Net Profit
294
EPS
21
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
21
Minority Interest
0
Share of Associates
0
Adjusted EPS
21
Mar 2019
897
563
Operating Profit
366
OPM %
41
Other Income
32
Interest
23
Depreciation
32
312
Tax %
8
Net Profit
285
EPS
21
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
21
Minority Interest
0
Share of Associates
0
Adjusted EPS
21
Mar 2020
1,020
665
Operating Profit
370
OPM %
36
Other Income
15
Interest
2
Depreciation
45
324
Tax %
10
Net Profit
291
EPS
21
Dividend Payout %
13
Minority Interest
0
Share of Associates
0
Adjusted EPS
21
Minority Interest
0
Share of Associates
0
Adjusted EPS
21
Mar 2021
1,109
691
Operating Profit
427
OPM %
39
Other Income
10
Interest
1
Depreciation
38
389
Tax %
10
Net Profit
351
EPS
26
Dividend Payout %
21
Minority Interest
0
Share of Associates
0
Adjusted EPS
26
Minority Interest
0
Share of Associates
0
Adjusted EPS
26
Mar 2022
1,216
732
Operating Profit
513
OPM %
42
Other Income
29
Interest
3
Depreciation
51
459
Tax %
9
Net Profit
417
EPS
31
Dividend Payout %
20
Minority Interest
0
Share of Associates
0
Adjusted EPS
31
Minority Interest
0
Share of Associates
0
Adjusted EPS
31
Mar 2023
1,331
826
Operating Profit
522
OPM %
39
Other Income
17
Interest
21
Depreciation
65
437
Tax %
9
Net Profit
398
EPS
29
Dividend Payout %
25
Minority Interest
0
Share of Associates
0
Adjusted EPS
29
Minority Interest
0
Share of Associates
0
Adjusted EPS
29
Mar 2024
1,487
1,033
Operating Profit
489
OPM %
33
Other Income
35
Interest
57
Depreciation
102
329
Tax %
9
Net Profit
300
EPS
22
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
22
Minority Interest
0
Share of Associates
0
Adjusted EPS
22
Mar 2025
1,698
1,211
Operating Profit
522
OPM %
31
Other Income
36
Interest
220
Depreciation
182
120
Tax %
36
Net Profit
77
EPS
6
Dividend Payout %
129
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
TTM
1,656
1,253
Operating Profit
OPM %
Other Income
102
Interest
177
Depreciation
157
270
Tax %
29
Net Profit
192
EPS
Dividend Payout %
Minority Interest
0
Share of Associates
0
Adjusted EPS
Minority Interest
0
Share of Associates
0
Adjusted EPS

COMPOUNDED SALES GROWTH

10 Years:
12%
5 Years:
11%
3 Years:
12%

COMPOUNDED PROFIT GROWTH

10 Years:
-1%
5 Years:
-23%
3 Years:
-43%

STOCK PRICE CAGR

10 Years:
5 Years:
13%
3 Years:
16%
1 Year:
-24%

RETURN ON EQUITY

10 Years:
28%
5 Years:
17%
3 Years:
12%
Last Year:
3%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

May 29

₹ 7.21

Rs.7.2100 per share(721%)Interim Dividend

2025

Feb 13

₹ 7.35

Interim Dividend

2022

Aug 11

₹ 7.35

Interim Dividend

2021

Aug 5

₹ 6.01

Interim Dividend

Mar 2016
Equity Capital
0
306
0
Trade Payables
28
63
Total Liabilities
397
65
Capital Work in Progress
0
206
49
0
Cash & Bank
9
68
Total Assets
397
Total Debt
0
Net Working Capital
166
Contingent Liabilities
0
Book Value per Share
22154.28
Face Value
10.00
Total Debt
0
Net Working Capital
166
Contingent Liabilities
0
Book Value per Share
22154.28
Face Value
10.00
Mar 2017
Equity Capital
14
561
0
Trade Payables
25
66
Total Liabilities
666
92
Capital Work in Progress
0
381
47
0
Cash & Bank
2
144
Total Assets
666
Total Debt
0
Net Working Capital
152
Contingent Liabilities
13
Book Value per Share
41.79
Face Value
1.00
Total Debt
0
Net Working Capital
152
Contingent Liabilities
13
Book Value per Share
41.79
Face Value
1.00
Mar 2018
Equity Capital
14
854
102
Trade Payables
79
293
Total Liabilities
1,342
490
Capital Work in Progress
0
546
58
0
Cash & Bank
9
241
Total Assets
1,342
Total Debt
376
Net Working Capital
106
Contingent Liabilities
14
Book Value per Share
63.14
Face Value
1.00
Total Debt
376
Net Working Capital
106
Contingent Liabilities
14
Book Value per Share
63.14
Face Value
1.00
Mar 2019
Equity Capital
14
1,141
176
Trade Payables
75
-3
Total Liabilities
1,402
484
Capital Work in Progress
1
580
75
0
Cash & Bank
6
256
Total Assets
1,402
Total Debt
176
Net Working Capital
259
Contingent Liabilities
15
Book Value per Share
83.97
Face Value
1.00
Total Debt
176
Net Working Capital
259
Contingent Liabilities
15
Book Value per Share
83.97
Face Value
1.00
Mar 2020
Equity Capital
14
1,283
0
Trade Payables
90
-14
Total Liabilities
1,373
601
Capital Work in Progress
0
320
65
0
Cash & Bank
65
321
Total Assets
1,373
Total Debt
0
Net Working Capital
300
Contingent Liabilities
16
Book Value per Share
95.51
Face Value
1.00
Total Debt
0
Net Working Capital
300
Contingent Liabilities
16
Book Value per Share
95.51
Face Value
1.00
Mar 2021
Equity Capital
14
1,558
0
Trade Payables
87
-32
Total Liabilities
1,626
584
Capital Work in Progress
0
531
65
0
Cash & Bank
33
413
Total Assets
1,626
Total Debt
0
Net Working Capital
279
Contingent Liabilities
18
Book Value per Share
115.74
Face Value
1.00
Total Debt
0
Net Working Capital
279
Contingent Liabilities
18
Book Value per Share
115.74
Face Value
1.00
Mar 2022
Equity Capital
14
1,903
0
Trade Payables
97
-16
Total Liabilities
1,998
642
Capital Work in Progress
0
778
85
0
Cash & Bank
46
447
Total Assets
1,998
Total Debt
0
Net Working Capital
414
Contingent Liabilities
24
Book Value per Share
141.00
Face Value
1.00
Total Debt
0
Net Working Capital
414
Contingent Liabilities
24
Book Value per Share
141.00
Face Value
1.00
Mar 2023
Equity Capital
14
2,205
55
Trade Payables
83
231
Total Liabilities
2,588
898
Capital Work in Progress
0
997
64
0
Cash & Bank
48
582
Total Assets
2,588
Total Debt
317
Net Working Capital
268
Contingent Liabilities
25
Book Value per Share
163.18
Face Value
1.00
Total Debt
317
Net Working Capital
268
Contingent Liabilities
25
Book Value per Share
163.18
Face Value
1.00
Mar 2024
Equity Capital
14
2,505
1,825
Trade Payables
110
653
Total Liabilities
5,107
1,516
Capital Work in Progress
0
1,619
92
240
Cash & Bank
1,297
344
Total Assets
5,107
Total Debt
2,529
Net Working Capital
-385
Contingent Liabilities
27
Book Value per Share
185.22
Face Value
1.00
Total Debt
2,529
Net Working Capital
-385
Contingent Liabilities
27
Book Value per Share
185.22
Face Value
1.00
Mar 2025
Equity Capital
14
2,491
356
Trade Payables
216
1,879
Total Liabilities
4,956
2,412
Capital Work in Progress
0
991
191
236
Cash & Bank
92
1,033
Total Assets
4,956
Total Debt
2,213
Net Working Capital
-366
Contingent Liabilities
30
Book Value per Share
183.90
Face Value
1.00
Total Debt
2,213
Net Working Capital
-366
Contingent Liabilities
30
Book Value per Share
183.90
Face Value
1.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016
133
Cash from Investing
-45
Cash from Financing
-84
4
Free Cash Flow
110
OCF / Net Profit
0.96
Cumulative 5-Year FCF
0
OCF / Net Profit
0.96
Cumulative 5-Year FCF
0
Mar 2017
210
Cash from Investing
-199
Cash from Financing
-18
-6
Free Cash Flow
205
OCF / Net Profit
0.85
Cumulative 5-Year FCF
0
OCF / Net Profit
0.85
Cumulative 5-Year FCF
0
Mar 2018
236
Cash from Investing
-593
Cash from Financing
363
7
Free Cash Flow
-183
OCF / Net Profit
0.80
Cumulative 5-Year FCF
0
OCF / Net Profit
0.80
Cumulative 5-Year FCF
0
Mar 2019
216
Cash from Investing
2
Cash from Financing
-221
-2
Free Cash Flow
197
OCF / Net Profit
0.76
Cumulative 5-Year FCF
0
OCF / Net Profit
0.76
Cumulative 5-Year FCF
0
Mar 2020
265
Cash from Investing
127
Cash from Financing
-334
58
Free Cash Flow
122
OCF / Net Profit
0.91
Cumulative 5-Year FCF
450
OCF / Net Profit
0.91
Cumulative 5-Year FCF
450
Mar 2021
395
Cash from Investing
-348
Cash from Financing
-81
-34
Free Cash Flow
374
OCF / Net Profit
1.13
Cumulative 5-Year FCF
714
OCF / Net Profit
1.13
Cumulative 5-Year FCF
714
Mar 2022
369
Cash from Investing
-268
Cash from Financing
-88
13
Free Cash Flow
303
OCF / Net Profit
0.89
Cumulative 5-Year FCF
812
OCF / Net Profit
0.89
Cumulative 5-Year FCF
812
Mar 2023
322
Cash from Investing
-513
Cash from Financing
194
3
Free Cash Flow
11
OCF / Net Profit
0.81
Cumulative 5-Year FCF
1,007
OCF / Net Profit
0.81
Cumulative 5-Year FCF
1,007
Mar 2024
336
Cash from Investing
-2,492
Cash from Financing
2,160
4
Free Cash Flow
-380
OCF / Net Profit
1.12
Cumulative 5-Year FCF
430
OCF / Net Profit
1.12
Cumulative 5-Year FCF
430
Mar 2025
702
Cash from Investing
-359
Cash from Financing
-310
32
Free Cash Flow
-362
OCF / Net Profit
9.07
Cumulative 5-Year FCF
-54
OCF / Net Profit
9.07
Cumulative 5-Year FCF
-54

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016
EPS (₹)
9997.90
Book Value (₹)
22154.28
Dividend per Share (₹)
6042.00
Cash EPS (₹)
0.00
Operating Margin %
27.88%
Net Margin %
22.14%
ROE %
48.12%
ROCE %
53.64%
36.93%
Debtor Days
14
Inventory Days
30
Payable Days
101
-56
Debt to Equity (x)
0.00x
Interest Coverage (x)
556.69x
3.35x
Revenue Growth %
10.49%
Operating Profit Growth %
48.15%
Net Profit Growth %
65.58%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2017
EPS (₹)
18.05
Book Value (₹)
41.79
Dividend per Share (₹)
0.00
Cash EPS (₹)
19.61
Operating Margin %
41.56%
Net Margin %
34.81%
ROE %
56.37%
ROCE %
62.40%
46.70%
Debtor Days
17
Inventory Days
25
Payable Days
71
-29
Debt to Equity (x)
0.00x
Interest Coverage (x)
321.83x
2.33x
Revenue Growth %
17.74%
Operating Profit Growth %
70.52%
Net Profit Growth %
79.85%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2018
EPS (₹)
21.36
Book Value (₹)
63.14
Dividend per Share (₹)
0.00
Cash EPS (₹)
22.94
Operating Margin %
45.25%
Net Margin %
38.61%
ROE %
40.71%
ROCE %
35.45%
29.24%
Debtor Days
24
Inventory Days
25
Payable Days
164
-114
Debt to Equity (x)
0.43x
Interest Coverage (x)
30.77x
1.38x
Revenue Growth %
6.69%
Operating Profit Growth %
16.16%
Net Profit Growth %
18.34%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2019
EPS (₹)
20.75
Book Value (₹)
83.97
Dividend per Share (₹)
0.00
Cash EPS (₹)
23.05
Operating Margin %
40.85%
Net Margin %
31.83%
ROE %
28.21%
ROCE %
25.98%
20.79%
Debtor Days
28
Inventory Days
27
Payable Days
212
-158
Debt to Equity (x)
0.15x
Interest Coverage (x)
14.61x
1.72x
Revenue Growth %
17.87%
Operating Profit Growth %
6.42%
Net Profit Growth %
-2.82%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2020
EPS (₹)
21.45
Book Value (₹)
95.51
Dividend per Share (₹)
2.87
Cash EPS (₹)
24.76
Operating Margin %
36.31%
Net Margin %
28.55%
ROE %
23.76%
ROCE %
24.74%
20.99%
Debtor Days
39
Inventory Days
25
Payable Days
183
-119
Debt to Equity (x)
0.00x
Interest Coverage (x)
165.51x
2.48x
Revenue Growth %
13.80%
Operating Profit Growth %
1.14%
Net Profit Growth %
2.06%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2021
EPS (₹)
25.82
Book Value (₹)
115.74
Dividend per Share (₹)
5.50
Cash EPS (₹)
28.59
Operating Margin %
37.62%
Net Margin %
30.86%
ROE %
24.45%
ROCE %
27.12%
23.38%
Debtor Days
41
Inventory Days
21
Payable Days
162
-101
Debt to Equity (x)
0.00x
Interest Coverage (x)
416.49x
2.31x
Revenue Growth %
8.68%
Operating Profit Growth %
15.39%
Net Profit Growth %
20.37%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2022
EPS (₹)
30.69
Book Value (₹)
141.00
Dividend per Share (₹)
6.01
Cash EPS (₹)
34.48
Operating Margin %
40.90%
Net Margin %
33.26%
ROE %
23.92%
ROCE %
26.42%
23.02%
Debtor Days
37
Inventory Days
22
Payable Days
168
-109
Debt to Equity (x)
0.00x
Interest Coverage (x)
151.29x
2.66x
Revenue Growth %
9.64%
Operating Profit Growth %
20.02%
Net Profit Growth %
18.99%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2023
EPS (₹)
29.27
Book Value (₹)
163.18
Dividend per Share (₹)
7.35
Cash EPS (₹)
34.02
Operating Margin %
38.09%
Net Margin %
29.02%
ROE %
19.25%
ROCE %
20.54%
17.36%
Debtor Days
49
Inventory Days
20
Payable Days
139
-70
Debt to Equity (x)
0.14x
Interest Coverage (x)
22.00x
1.74x
Revenue Growth %
9.46%
Operating Profit Growth %
1.82%
Net Profit Growth %
-4.60%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2024
EPS (₹)
22.04
Book Value (₹)
185.22
Dividend per Share (₹)
0.00
Cash EPS (₹)
29.57
Operating Margin %
29.05%
Net Margin %
19.19%
ROE %
12.65%
ROCE %
10.18%
7.79%
Debtor Days
55
Inventory Days
18
Payable Days
126
-53
Debt to Equity (x)
1.00x
Interest Coverage (x)
6.73x
0.83x
Revenue Growth %
11.72%
Operating Profit Growth %
-6.46%
Net Profit Growth %
-24.70%
-24.70%
P/E (x)
38.17x
P/B (x)
4.54x
Dividend Yield %
0.00%
25.93x
Mar 2025
EPS (₹)
5.68
Book Value (₹)
183.90
Dividend per Share (₹)
7.35
Cash EPS (₹)
19.03
Operating Margin %
28.02%
Net Margin %
4.46%
ROE %
3.08%
ROCE %
6.96%
1.54%
Debtor Days
50
Inventory Days
30
Payable Days
119
-39
Debt to Equity (x)
0.88x
Interest Coverage (x)
1.55x
0.64x
Revenue Growth %
14.20%
Operating Profit Growth %
6.84%
Net Profit Growth %
-74.18%
-74.22%
P/E (x)
249.29x
P/B (x)
7.70x
Dividend Yield %
0.52%
41.02x

Shareholding Pattern

Numbers in percentages

TRADES
Jun 2024
54.88
14.59
16.23
Government
0.00
14.30
Sep 2024
54.87
8.00
18.64
Government
0.00
18.47
Dec 2024
54.86
8.36
18.07
Government
0.00
18.72
Mar 2025
54.85
8.43
18.07
Government
0.00
18.66
Jun 2025
54.83
8.39
18.18
Government
0.00
18.59
Sep 2025
54.85
7.21
19.36
Government
0.00
18.57
Dec 2025
54.85
6.85
20.31
Government
0.00
17.99
Mar 2026
53.92
6.39
20.35
Government
0.00
19.33
Jun 2026
54.14
5.76
20.71
Government
0.00
19.40

Documents

Announcements

Credit Ratings

  • Credit Rating

    2026-05-08 - Eris Lifesciences Limited has informed the Exchange about Credit Rating

Concalls